Modifications in the papillary thyroid cancer gene profile over the last 15 years

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages

  Romei, Cristina ^a   Fugazzola, Laura ^b   Puxeddu, Efisio ^d   Frasca, Francesco ^e   Viola, David ^a   Muzza, Marina ^b   Moretti, Sonia ^d   Nicolosi, Maria Luisa ^e   Giani, Carlotta ^a   Cirello, Valentina ^b   Avenia, Nicola ^d   Rossi, Stefania ^c   Vitti, Paolo ^a   Pinchera, Aldo ^a   Elisei, Rossella ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGED; ARTICLE; BRAF V600E GENE; CANCER INCIDENCE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; ONCOGENE; PRIORITY JOURNAL; RACE DIFFERENCE; RET PTC GENE; SCHOOL CHILD; SYNDROME DELINEATION; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADULT; AGE OF ONSET; AGED; CARCINOMA, PAPILLARY; COHORT STUDIES; DNA FINGERPRINTING; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT; GENETIC VARIATION; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; SICILY; THYROID NEOPLASMS;

EID: 84866145911     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1269     Document Type: Article

References (44)

1. Braverman LE 2000 The thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams, Wilkins
2. Greco A, Borrello MG, Miranda C, Degl'Innocenti D, Pierotti MA 2009 Molecular pathology of differentiated thyroid cancer. QJ Nucl Med Mol Imaging 53:440-453
3. Nikiforov YE 2002 RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13:3-16 (Pubitemid 34665111)
4. Ciampi R, Nikiforov YE 2007 RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology 148:936-941
5. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57:1690-1694 (Pubitemid 27199660)
6. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F 2001 RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-3216 (Pubitemid 32673490)
7. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, Pacini F, Pierotti MA 1995 Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55:5617-5620
8. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G 1999 High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84:4232-4238 (Pubitemid 30644223)
9. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625-627 (Pubitemid 36553510)
10. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA 2002 Mutations of the BRAF gene in human cancer. Nature 417:949-954 (Pubitemid 34716871)
11. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404 (Pubitemid 37452745)
12. Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R 2006 Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer 13:455-464 (Pubitemid 43886668)
13. Xing M 2005 BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245-262 (Pubitemid 40896444)
14. Xing M 2007 BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 28:742-762 (Pubitemid 350294294)
15. Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simõ es M 2005 Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch 446:589-595
16. Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R 2008 BRAF (V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer 15:191-205 (Pubitemid 351449739)
17. Sassolas G, Hafdi-Nejjari Z, Ferraro A, Decaussin-Petrucci M, Rousset B, Borson-Chazot F, Borbone E, Berger N, Fusco A 2012 Oncogenic alterations in papillary thyroid cancers of young patients. Thyroid 22:17-26
18. Collins BJ, Schneider AB, Prinz RA, Xu X 2006 Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure. Thyroid 16:61-66 (Pubitemid 43346505)
19. Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE 2005 Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94-101 (Pubitemid 40385509)
20. Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F 2008 BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab 93:3943-3949
21. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A 2010 Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95:1516-1527
22. Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM 2011 The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21:231-236
23. Smyth P, Finn S, Cahill S, O'Regan E, Flavin R, O'Leary JJ, Sheils O 2005 ret/PTC and BRAF act as distinct molecular, time-dependant triggers in a sporadic Irish cohort of papillary thyroid carcinoma. Int J Surg Pathol 13:1-8 (Pubitemid 40224091)
24. Mathur A, Moses W, Rahbari R, Khanafshar E, Duh QY, Clark O, Kebebew E 2011 Higher rate of BRAF mutation in papillary thyroid cancer over time: A single-institution study. Cancer 117:4390-4395
25. Hedinger C 1988 Histological typing of thyroid tumors: WHO international histological classification of tumors. 2nd ed. New York, Berlin, Heidelberg: Springer-Verlag
26. Greene FL, Page DL, Fleming ID, Fritz A, Baclch CM, Haller DG, Morrow M 2002 American Joint Committee of Cancer 2002 cancer staging manual. 6th ed. New York: Springer-Verlag
27. Romei C, Ciampi R, Faviana P, Agate L, Molinaro E, Bottici V, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R 2008 BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer. Endocr Relat Cancer 15:511-520 (Pubitemid 351880839)
28. Romei C, Elisei R 2012 RET/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma. Front Endocrinol (Lausanne) 3:54
29. Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, Carr Z, Chumak V, Davis S, Demidchik Y, Drozdovitch V, Gentner N, Gudzenko N, Hatch M, Ivanov V, Jacob P, Kapitonova E, Kenigsberg Y, Kesminiene A, Kopecky KJ, Kryuchkov V, Loos A, Pinchera A, Reiners C, Repacholi M, Shibata Y, Shore RE, Thomas G, Tirmarche M, Yamashita S, Zvonova I 2006 Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 26:127-140 (Pubitemid 43861071)
30. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA, Nikiforov YE 2000 Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290:138-141
31. Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D 1992 Thyroid cancer after Chernobyl. Nature 359:21-22
32. Williams D 2008 Twenty years' experience with post-Chernobyl thyroid cancer. Best Pract Res Clin Endocrinol Metab 22:1061-1073
33. Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D, Klugbauer S 2000 Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res 6:1093-1103 (Pubitemid 30159372)
34. Chiesa F, Tradati N, Calabrese L, Gibelli B, Giugliano G, Paganelli G, De Cicco C, Grana C, Tosi G, DeFiori E, Cammarano G, Cusati A, Zurrida S 2004 Thyroid disease in northern Italian children born around the time of the Chernobyl nuclear accident. Ann Oncol 15:1842-1846 (Pubitemid 40012251)
35. Singh SK, Wang M, Staudt C, Iliakis G 2011 Post-irradiation chemical processing of DNA damage generates double-strand breaks in cells already engaged in repair. Nucleic Acids Res 39:8416-8429
36. Williams ED 1979 The aetiology of thyroid tumours. Clin Endocrinol Metab 8:193-207 (Pubitemid 9126107)
37. Williams ED, Doniach I, Bjarnason O, Michie W 1977 Thyroid cancer in an iodide rich area: a histopathological study. Cancer 39:215-222 (Pubitemid 8029001)
38. Vejbjerg P, Knudsen N, Perrild H, Carle A, Laurberg P, Pedersen IB, Rasmussen LB, Ovesen L, Jorgensen T 2007 Effect of a mandatory iodization program on thyroid gland volume based on individuals'age, gender, and preceding severity of dietary iodine deficiency: a prospective, population-based study. J Clin Endocrinol Metab 92:1397-1401 (Pubitemid 46556416)
39. Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P, Zhang Y, Shan Z, Teng W, Xing M 2009 Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab 94:1612-1617
40. Somers CM, Yauk CL, White PA, Parfett CL, Quinn JS 2002 Air pollution induces heritable DNA mutations. Proc Natl Acad Sci USA 99:15904-15907 (Pubitemid 35462721)
41. Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S, Dardanoni G, Frasca F, Malandrino P, Vermiglio F, Previtera DM, D'Azzò G, Trimarchi F, Vigneri R 2009 Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 101:1575-1583
42. Sinnott B, Ron E, Schneider AB 2010 Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 31:756-773
43. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
44. Ugolini C, Giannini R, Lupi C, Salvatore G, Miccoli P, Proietti A, Elisei R, Santoro M, Basolo F 2007 Presence of BRAFV600E in very early stages of papillary thyroid carcinoma. Thyroid 17:381-388 (Pubitemid 46878840)